VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 50 filers reported holding VINCERX PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,902 | -24.3% | 64,259 | -2.5% | 0.00% | – |
| Q2 2023 | $85,716 | -28.2% | 65,935 | -42.6% | 0.00% | – |
| Q1 2023 | $119,451 | -15.8% | 114,857 | -17.4% | 0.00% | – |
| Q4 2022 | $141,827 | -25.7% | 139,046 | +0.2% | 0.00% | – |
| Q3 2022 | $191,000 | +1.6% | 138,770 | -2.5% | 0.00% | – |
| Q2 2022 | $188,000 | -93.9% | 142,389 | -81.5% | 0.00% | – |
| Q1 2022 | $3,083,000 | -60.8% | 771,004 | -0.2% | 0.00% | – |
| Q4 2021 | $7,870,000 | -33.2% | 772,278 | +6.1% | 0.00% | – |
| Q3 2021 | $11,773,000 | +177.9% | 728,091 | +123.2% | 0.00% | – |
| Q2 2021 | $4,237,000 | +142.1% | 326,234 | +259.5% | 0.00% | – |
| Q1 2021 | $1,750,000 | – | 90,753 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,658,199 | $2,189,000 | 0.84% |
| Affinity Asset Advisors, LLC | 1,374,098 | $1,814,000 | 0.76% |
| SABBY MANAGEMENT, LLC | 500,559 | $661,000 | 0.45% |
| TANG CAPITAL MANAGEMENT LLC | 1,030,634 | $1,360,000 | 0.21% |
| Rubric Capital Management LP | 2,107,000 | $2,781,000 | 0.15% |
| Long Focus Capital Management, LLC | 980,000 | $1,294,000 | 0.14% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $508,000 | 0.09% |
| Clearline Capital LP | 452,184 | $597,000 | 0.08% |
| Sio Capital Management, LLC | 102,049 | $135,000 | 0.05% |
| Rock Springs Capital Management LP | 814,194 | $1,075,000 | 0.03% |